secwatch.observer — SEC 8-K summary
======================================

Issuer:     NutriBand Inc. (NTRB)
CIK:        0001676047
Form:       8-K
Filed at:   2026-06-22T12:02:58+00:00
Accession:  0001213900-26-070378
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutriband enters amended $5M credit line at 7% interest for AVERSA Fentanyl
---------------------------------------------------------------------------

- $5M credit line facility amended as of June 1, 2026, replacing prior $5M facility expiring July 2026.
- Interest at 7% per annum; no conversion rights for lender into common stock.
- Proceeds for commercialization of AVERSA Fentanyl, including FDA submission and manufacturing costs with Kindeva Drug Delivery.
- Maturity date July 1, 2029; advances allowed only after commencement of NDA-related work with Kindeva.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676047/000121390026070378/0001213900-26-070378-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676047/000121390026070378/ea0295410-8k_nutriband.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-070378

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer